Learn how to leverage solutions from QIAGEN Digital Insights to discover biomarkers, validate targets, and identify variants.

Attendees will learn to:

1. Locate public studies of interest using OmicSoft DiseaseLand

2. Investigate expression of genes of interest across different treatments, disease states, etc.

3. Identify variants of interest for candidate biomarkers and targets using Human Gene Mutation Database (HGMD)

4. Leverage the QIAGEN Knowledgebase in Ingenuity Pathway Analysis (IPA) to explore and extend findings from OmicSoft DiseaseLand and HGMD

5. Access data from OmicSoft, HGMD and IPA in ways that are helpful for data scientists